Clinical trial · Interventional
Development Of An Endometrial Cancer Educational Tool
NCT07739745CI-TRIAL-00120181not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interactive Educational Website | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Healthcare Providers
- description
- Healthcare providers will be recruited from MD Anderson Cancer Center and outside institutions to reflect a broad group of physicians
- interventionNames
- Other: Interactive Educational Website
- type
- EXPERIMENTAL
- label
- Patients
- description
- Participants will be recruited from the University of Texas MD Anderson Cancer Center (MDA), MDA Houston Area Locations (HALs), and The Harris Health System (LBJ).
- interventionNames
- Other: Interactive Educational Website
Primary outcomes (1)
- measure
- Safety and Adverse Events (AEs)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients: Study Objective 1 (Part A-C see Figure 2) 1. Women who have been diagnosed with endometrial cancer 2. Must be at least 18 years old 3. Must read and speak English or Spanish 4. Must provide written informed consent Study Objectives 2 and 3 (Pilot Study) 1. Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment 2. Must be at least 18 years old 3. Must read and speak English or Spanish 4. Must provide written informed consent. Physicians: Study Objective 1 (Qualitative Interviews) 1. Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions 2. Must be able to speak and read English 3. Must provide written informed consent Healthcare Providers: Study Objectives 2 and 3 (Pilot Study) 1. Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer 2. Must be able to speak and read English 3. Must provide written informed consent Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.